SOX21
Transcription factor SOX-21
Also known as: SOX21_HUMAN, SOX25
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y651
- Gene
- SOX21
- Ensembl
- ENSG00000125285
- Chromosome
- 13
- Canonical length
- 276 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
SRY-related HMG-box (SOX) genes encode a family of DNA-binding proteins containing a 79-amino acid HMG (high mobility group) domain that shares at least 50% sequence identity with the DNA-binding HMG box of the SRY protein (MIM 480000). SOX proteins are divided into 6 subgroups based on sequence similarity within and outside of the HMG domain. For additional background information on SOX genes, see SOX1 (MIM 602148).[supplied by OMIM, Apr 2004]
Canonical amino-acid sequenceUniProt
276 residues, UniProt reviewed canonical sequence.
>Q9Y651|SOX21
1 MSKPVDHVKR PMNAFMVWSR AQRRKMAQEN PKMHNSEISK RLGAEWKLLT ESEKRPFIDE
61 AKRLRAMHMK EHPDYKYRPR RKPKTLLKKD KFAFPVPYGL GGVADAEHPA LKAGAGLHAG
121 AGGGLVPESL LANPEKAAAA AAAAAARVFF PQSAAAAAAA AAAAAAGSPY SLLDLGSKMA
181 EISSSSSGLP YASSLGYPTA GAGAFHGAAA AAAAAAAAAG GHTHSHPSPG NPGYMIPCNC
241 SAWPSPGLQP PLAYILLPGM GKPQLDPYPA AYAAALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SOX21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- stomach: 33 nTPM
- skin: 15 nTPM
- amygdala: 12 nTPM
- basal ganglia: 11 nTPM
- cerebral cortex: 9.8 nTPM
- esophagus: 9.6 nTPM
Single-cell type
- foveolar cells: 102 nCPM
- oligodendrocyte progenitor cells: 32 nCPM
- respiratory secretory cells: 31 nCPM
- mucous neck cells: 29 nCPM
- respiratory deuterosomal cells: 28 nCPM
- conjunctival goblet cells: 20 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 18 nTPM
- thalamus: 18 nTPM
- amygdala: 17 nTPM
- basal ganglia: 17 nTPM
- hypothalamus: 16 nTPM
- spinal cord: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0.71
- gnomAD missense Z
- 1.74
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- hair follicle development
- negative regulation of transcription by RNA polymerase II
- neuron differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- stem cell differentiation
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SOX21 as an antibody target. Whether an autoantibody or antibody against SOX21 could matter depends on whether native SOX21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SOX21 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SOX21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...